(PRWEB) November 18, 2014
Cristcot Inc., a global life sciences company focused on the development and commercialization of specialized drug delivery systems, today announced that the Japanese Patent Office has granted Cristcot a patent for the technology, which encompasses the company’s commercially available suppository applicator, Sephure®.
The patent was awarded to the inventor Jennifer Davagian Ensign and the property rights have been assigned to Cristcot Inc. The patented technology, titled “Method and Apparatus for Inserting a Rectal Suppository,” provides Cristcot with intellectual property protection in Japan.
"Congratulations to Cristcot founder Jennifer Ensign and her team on reaching an important milestone that will open up new markets for the company's product," said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center. "The Center awarded Cristcot Medical a $257,000 Accelerator Loan in 2012 to support the development of Sephure. This and other new technologies that the Center has supported are helping people, not just in Massachusetts, but across the globe."
The Sephure suppository applicator is recognized by healthcare providers across the globe as a simple, cost effective device for strengthening infection control programs while improving the quality of patient care for the administration of suppository medication.
“We are thrilled to have the opportunity to introduce Sephure to the Japanese healthcare community,” said Davagian Ensign. “Sephure revitalizes the delivery of suppositories, allowing fast, comfortable and hygienic administration, making it practical for patients and healthcare providers in the 21st century.”
About Cristcot Inc.
Cristcot Inc. is a global life sciences company focused on the development and commercialization of specialized drug delivery systems that improve the quality of patient care. Founded in 2008 by Jennifer Davagian Ensign, Cristcot introduced the commercially available suppository applicator, Sephure® to market earlier this year. Sephure is the first and only disposable rectal suppository applicator cleared by the U.S. Food and Drug Administration for administering over-the-counter and prescription suppository medications. The company is headquartered in Concord, Massachusetts and is funded in part by the Massachusetts Life Science Center. For more information, please visit http://www.sephure.com and connect with us on Facebook, Twitter, and Instagram.